Abridge Secures $250M Series D Funding and Launches AI Engine
Abridge has raised $250 million in Series D funding and introduced a new Contextual Reasoning Engine to enhance clinical workflows, announced in a press release.
Applications of AI in healthcare, including medical diagnostics, drug discovery, patient care solutions, and biotechnology research.
Abridge has raised $250 million in Series D funding and introduced a new Contextual Reasoning Engine to enhance clinical workflows, announced in a press release.
Fosun Pharma has introduced its self-developed PharmAID decision intelligence platform, integrating advanced AI technologies to boost drug R&D efficiency, announced in a press release.
Researchers are developing AI systems to interpret animal emotions, such as the Intellipig system for pigs and facial recognition for dogs, according to TechCrunch.
Freedom International Group (FIG) has announced a strategic investment in Elitepharm Laboratoires, aiming to enhance dietary supplement production with AI technology.
Saudi Arabia's Neom project has partnered with Paradromics to advance brain-computer interface technology, aiming to establish a Center of Excellence in the region.
Infinx Healthcare is set to debut its Revenue Cycle Agent Platform and Document Capture AI Platform at ViVE 2025 in Nashville, Tennessee, according to a press release.
Ping An Health has integrated the DeepSeek large language model to enhance its AI-driven healthcare services, improving disease diagnosis and personalized health management.
AIRS Medical partners with Incepto to bring SwiftMR, an AI-powered MRI reconstruction technology, to diagnostic imaging providers across Europe, aiming to reduce scan times and improve image quality.
Keragon, an AI-driven healthcare automation platform, has raised $7.5 million in a seed funding round, boosting its total funding to $10.5 million.
ArisGlobal has signed the EU AI Pact, reinforcing its commitment to ethical AI practices and preparing for the EU AI Act.
Fabric Labs Inc. unveils Hybrid AI, a technology designed to improve patient care and engagement, recognized as a leader in conversational AI by Frost & Sullivan.
King's College London researchers receive additional funding to expand AI-driven analysis of electronic health records, aiming to identify risk factors for drug-resistant epilepsy.